Hedge Funds Similar to Samsara BioCapital

13F Portfolio OverlapQ2 2026Samsara BioCapital portfolio →
Institutional-grade research for retail investors

Most similar hedge funds by 13F overlap

Samsara BioCapital, LLC is an institutional investor managing $1.2B across 24 U.S. equity positions as of Q2 2026. Based on the overlap of conviction holdings in their latest 13F filings, the hedge funds with portfolios most similar to Samsara BioCapital are Redmile Group, Foresite VI, Andera Partners, with shared positions in $SRRK, $NGNE, $AGMB, $ALMS, $JBIO, $PBLS. The full ranking of 25 similar funds is below.

#1Redmile Group, LLCSmart money
Notable overlap · 3 shared positions
$1.5B
39 positions
Notable overlap · 3 shared positions
$643M
23 positions
Notable overlap · 4 shared positions
$206M
8 positions
Notable overlap · 4 shared positions
$4.9B
117 positions
Notable overlap · 3 shared positions
$697M
23 positions
Notable overlap · 7 shared positions
$11.5B
84 positions
Notable overlap · 3 shared positions
$1.0B
15 positions
Notable overlap · 3 shared positions
$532M
39 positions
Some overlap · 3 shared positions
$1.1B
27 positions
Some overlap · 3 shared positions
$529M
42 positions
Some overlap · 4 shared positions
$2.0B
50 positions
Some overlap · 4 shared positions
$136M
35 positions
#13Casdin Capital, LLCSmart money
Some overlap · 5 shared positions
$2.0B
43 positions
Some overlap · 4 shared positions
$581M
84 positions
Some overlap · 3 shared positions
$928M
156 positions
Some overlap · 4 shared positions
$630M
35 positions
Some overlap · 5 shared positions
$1.6B
26 positions
Some overlap · 3 shared positions
$140M
23 positions
Some overlap · 3 shared positions
$113M
25 positions
Some overlap · 4 shared positions
$2.2B
113 positions
Some overlap · 4 shared positions
$542M
48 positions
Some overlap · 4 shared positions
$164M
51 positions
Some overlap · 4 shared positions
$191M
29 positions
Some overlap · 4 shared positions
$2.2B
277 positions
Slight overlap · 3 shared positions
$2.3B
68 positions

Compare Samsara BioCapital’s portfolio side by side

See the exact shared positions, conviction overlap, sector alignment, and where these funds diverge — and run the same analysis on any of 8,700+ institutions.

Similarity is derived from each fund’s latest 13F-HR filing with the SEC. Funds are ranked by the overlap of distinctive conviction holdings; near-universal mega-cap positions are excluded so the ranking reflects shared strategy, not common index exposure. Data is informational only and not investment advice.